Gene Therapy - Virus Safety Testing Services Market Statistics
The global gene therapy virus safety testing services market size was valued at US$ 118.9 million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 13.6% from 2021 to 2028.
Related Statistics
Gene therapy - Virus safety testing services market highlights
- The global gene therapy segment generated a revenue of USD 118.9 million in 2021 and is expected to reach USD 289.8 million by 2028.
- The market is expected to grow at a CAGR (2022 - 2028) of 13.5% by 2028.
- In terms of region, North America was the largest revenue generating market in 2021.
- Country-wise, China is expected to register the highest CAGR from 2022 to 2028.
Market summary
| Market revenue in 2021 | USD 118.9 million |
| Market revenue in 2028 | USD 289.8 million |
| Growth rate | 13.5% (CAGR from 2022 to 2028) |
| Historical data covered | 2016 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Virus Safety Testing Services Market Scope
Virus safety testing services market segmentation & scope
Virus Safety Testing Services Market Outlook
- HTML
- PPT
- -
Everything on Virus Safety Testing Services Market Outlook in one document: edited and divided into chapters, including detailed references.
Related industry reports
Related Regional Reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
